The German company last year approached the Intellectual Property Appellate Board after the local patent authority granted a "compulsory license" to Natco Pharma Ltd.
This change could force a compulsorylicense on the patentee -- and likely violate the "exclusive" ownership rights guaranteed in the Constitution and essential to U.S. innovation.
The appellate board, which is based in the southern city of Chennai, said the patent authority was right in allowing a compulsorylicense for Nexavar as Bayer hadn't priced the drug at "reasonably affordable" rates.